Breaking News

BioDlink Gains Argentina GMP Certification

This adds to BioDlink's portfolio of international GMP approvals, following recent certifications in Brazil, Indonesia, Egypt, and Colombia.

By: Rachel Klemovitch

Assistant Editor

BioDlink has been granted GMP certification by the National Administration of Drugs, Food and Medical Technology (ANMAT) of Argentina.  This follows recent certifications in Brazil, Indonesia, Egypt, and Colombia. The GMP inspection, conducted by ANMAT, focused on a commercial manufacturing facility in Suzhou, China, where biosimilar products are produced, including Pusintin (bevacizumab) injection.  This inspection represents BioDlink’s facilities and processes were found to...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters